Asymmetric phase-transfer catalysis (PTC) is one of the most practical methods for enantioselective synthesis.^[@ref1]^ For many years, PTC approaches to asymmetric fluorinations have used F~2~-derived electrophilic reagents and cationic or anionic chiral species for effective phase-transfer.^[@ref2]^ Inspired by nature's fluorinase,^[@ref3]^ we reported a complementary hydrogen bonding phase-transfer catalysis (HB-PTC) manifold that employed alkali metal fluorides for asymmetric nucleophilic fluorinations.^[@ref4]^ Specifically, a chiral *N*-alkylated *bis*-urea served as the hydrogen bond donor (HBD) catalyst to bring KF or CsF in solution. The process involves a chiral urea--fluoride complex that is capable of ion-pairing with in situ-formed *meso*-episulfonium or -aziridinium ions. The ensuing enantioselective desymmetrization afforded enantioenriched β-fluorosulfides and β-fluoroamines. To date, all enantioselective fluorinations carried out under PTC use nonionic substrates, including β-keto esters, alkenes, β-bromosulfides or β-chloroamines. An unexplored scenario in asymmetric C--F bond construction under PTC is the use of two ionic reactants. We became interested in this challenge as we envisioned that enantioselective desymmetrization of achiral azetidinium salts with fluoride would afford γ-fluoroamines of high value for medicinal chemistry.^[@ref5]^ Azetidinium salts^[@ref6]^ with non-nucleophilic counteranions are bench-stable solids^[@cit7a]^ and can be prepared from commercially available^[@cit7b]^ or readily synthesized^[@cit7c]^ azetidines. Few methods are available to access enantioenriched γ-fluoroamines,^[@ref8]^ and strategies for the enantioselective installation of CH~2~F are scarce.^[@ref9]^

In 2018, Sun and co-workers reported the desymmetrization of azetidinium salts with mercaptobenzothiazoles and a chiral phosphate catalyst ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}A, left).^[@ref10]^ This pioneering study encouraged experimentation applying this anionic PTC approach (CAPT) with TBAF or CsF; none of our attempts yielded γ-fluoroamines ([Scheme S6](http://pubs.acs.org/doi/suppl/10.1021/jacs.0c05131/suppl_file/ja0c05131_si_001.pdf)). This result prompted the use of HB-PTC as an alternative manifold. Mechanistically, achiral azetidinium salts could themselves act as phase-transfer agents enabling solubilization of solid alkali metal fluorides as azetidinium fluorides. Indeed, ammonium salts,^[@cit11a]−[@cit11c]^ pyridinium salts,^[@cit11d]^ and imidazolium-based ionic liquids^[@cit11e]^ have been used as phase-transfer catalysts for non-enantioselective fluorination reactions with KF or CsF ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}B, left).^[@cit11f],[@cit11g]^ Such a cationic phase-transfer catalysis (CPTC) scenario would transform *in situ*-formed azetidinium fluoride into racemic γ-fluoroamine. We envisioned that HB-PTC using a chiral *bis*-urea catalyst could offer a viable approach for the desymmetrization of achiral azetidinium salts with alkali metal fluorides ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}A,B, right). This scenario is not without challenges because the use of two preformed ionic reactants implies a high concentration of ions in solution, a drastic change compared with transformations featuring transiently formed ion pairs.^[@cit4a],[@cit4b]^ Significant variation in the fluorination kinetics and competitive binding events (e.g. azetidinium counteranion X^--^ vs F^--^) can be expected.^[@ref12]^ Computational studies indicated that a neutral chiral *N*-methyl-*bis*(urea)^[@cit4a]^ binds a CsF unit more strongly than 1,1-dimethylazetidinium ion in 1,2-dichloroethane (1,2-DCE) (Δ*G*~urea~ = −69 kJ/mol, Δ*G*~azet~ = −14 kJ/mol; [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}C).^[@cit13a]^

![(A) Desymmetrization of Azetidinium Salts; (B) R~4~N^+^X^--^ as a Catalyst (CPTC) versus R~4~N^+^X^--^ as a Substrate (HB-PTC); (C) Computational Binding Studies (R~4~N^+^X^--^ Treated as a Dissociated Species)](ja0c05131_0003){#sch1}

Encouraged by these findings,^[@cit13b]^ we surmised that azetidinium salts (R~4~N^+^X^--^) could undergo enantioselective fluorination with an alkali metal fluoride (M^+^F^--^) in the presence of a chiral HBD catalyst (urea\*) if orchestrated hydrogen bonding and ion metathesis generate the soluble chiral ion pair \[R~4~N\]^+^\[F·urea\*\]^−^. This species could undergo C--F bond formation with release of the enantioenriched γ-fluoroamine and the catalyst. Herein we describe the development of this unusual PTC process featuring two ionic reactants and demonstrate that achiral azetidinium salts are amenable to desymmetrization with CsF and a chiral BINAM-derived *bis*-urea catalyst.

Preliminary investigations unveiled details of the impact of the structural features of azetidinium salts on the reactivity ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). 3-Phenyl *N*,*N*-dibenzyl and *N*-methyl-*N*-benzylazetidinium triflates afforded traces of product with CsF and catalyst (*S*)-**A** ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 1 and 2). When *N*-methyl-*N*-benzhydryl substrate **1a** was employed, the desired γ-fluoroamine was obtained in poor yield and enantioselectivity ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 3). Notably, **1a** reacted with CsF in 1,2-DCE in the absence of catalyst to afford γ-fluoroamine (±)-**2a** in 8% yield ([Table S1](http://pubs.acs.org/doi/suppl/10.1021/jacs.0c05131/suppl_file/ja0c05131_si_001.pdf)). When this reaction was carried out using the *N*-alkyl-*bis*(urea) catalyst (*S*)-**B**, (*S*)-**C**, or (*S*)-**D**, **2a** was obtained in moderate yield and enantiomeric ratio (e.r.) ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 4--6). Solvent screening showed the superiority of 1,2-DCE (up to 81:19 e.r.; [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 7--9). In addition to the benzhydryl group, the second *N*-substituent also influenced the reactivity and enantioselectivity, with benzyl and ethyl being superior to methyl (up to 96:4 e.r.; [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entries 10--13). After optimization, the reaction of **1aa** (1:1.1 d.r.) in 1,2-DCE with CsF (2 equiv) and *N*-isopropyl-*bis*(urea) catalyst (*S*)-**D** (5 mol%) at room temperature afforded γ-fluoroamine **2aa** in 98% yield with 96:4 e.r. ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 13). *N*-Ethylazetidinium triflate **1ab** required a longer reaction time (72 h) and a higher catalyst loading (10 mol%) to afford **2ab** (93% yield, 96:4 e.r.; [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 11). These findings were encouraging because azetidinium salts can be used as mixtures of diastereomers, and both benzhydryl and benzyl groups are cleavable, releasing a primary amine that is amenable to myriad transformations.

###### Optimization of the Reaction Conditions[a](#t1fn1){ref-type="table-fn"}

![](ja0c05131_0006){#dgr1}

  entry                                                                   R^1^   R^2^   cat.   solvent      yield[b](#t1fn2){ref-type="table-fn"}   e.r.[c](#t1fn3){ref-type="table-fn"}
  ----------------------------------------------------------------------- ------ ------ ------ ------------ --------------------------------------- --------------------------------------
  1                                                                       Bn     Bn     A      CH~2~Cl~2~   traces                                  --
  2                                                                       Me     Bn     A      CH~2~Cl~2~   traces                                  --
  3                                                                       Me     Bzh    A      CH~2~Cl~2~   14%                                     55:45
  4                                                                       Me     Bzh    B      CH~2~Cl~2~   20%                                     55:45
  5                                                                       Me     Bzh    C      CH~2~Cl~2~   20%                                     75:25
  6                                                                       Me     Bzh    D      CH~2~Cl~2~   45%                                     74:26
  7                                                                       Me     Bzh    D      CHCl~3~      56%                                     67:33
  8                                                                       Me     Bzh    D      1,2-DFB      47%                                     79:21
  9                                                                       Me     Bzh    D      1,2-DCE      51%                                     81:19
  10                                                                      Et     Bzh    D      1,2-DCE      40%                                     96:4
  11[d](#t1fn4){ref-type="table-fn"}^,^[e](#t1fn5){ref-type="table-fn"}   Et     Bzh    D      1,2-DCE      93%                                     96:4
  12                                                                      Bn     Bzh    D      1,2-DCE      \>95%                                   96:4
  13[d](#t1fn4){ref-type="table-fn"}^,^[f](#t1fn6){ref-type="table-fn"}   Bn     Bzh    D      1,2-DCE      98%                                     96:4

Reaction conditions: 0.05 mmol of **1**, 0.25 M, 10 mol% cat., stirring at 900 rpm, 24 h.

Determined by ^19^F NMR spectroscopy with 4-fluoroanisole as an internal standard.

Enantiomeric ratios were determined by HPLC using a chiral stationary phase.

Yield of isolated product.

72 h, 10 mol% cat.

48 h, 5 mol% cat.

The benefit of the *N*-benzhydryl group on reactivity prompted further investigation.^[@ref14]^ Fluorination reactions performed on differently *N*,*N*-disubstituted azetidinium salts under homogeneous conditions (TBAF·3H~2~O, 1,2-DCE, no catalyst) showed benzhydryl to be superior to all other *N*-substituents ([Scheme S4](http://pubs.acs.org/doi/suppl/10.1021/jacs.0c05131/suppl_file/ja0c05131_si_001.pdf)). The increased reactivity of *N*-benzhydrylazetidinium salts is therefore unconnected with phase-transfer. Computed transition state (TS) structures for the fluorination of seven azetidinium ions by free fluoride (homogeneous conditions) showed that the increased experimental yields are consistent with smaller computed activation barriers. *N*-Benzhydrylazetidinium ions have barriers to fluorination that are ∼6 kJ/mol lower than those for the corresponding *N*-benzyl substrates. This can be traced to increased reactant strain: *N*-benzhydrylazetidinium ions have more elongated C--N bonds and earlier fluoride delivery TS positions compared with the methyl or benzyl substrates ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).

![Effect of the *N*-benzhydryl group on the reactivity (Me, Bn and Bzh series). The intrinsic reaction coordinate position was calculated as the C--N distance minus the C--F distance.^[@ref15]^](ja0c05131_0001){#fig1}

The scope of γ-fluoroamine synthesis was examined next ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). High yields and enantioselectivities were obtained with 3-arylazetidinium triflates. Substrates bearing aromatic groups with electron-withdrawing and electron-donating substituents at the *meta* or *para* position were converted in excellent yields and enantioselectivities (**2aa**--**2ha**, up to 99% yield, 97.5:2.5 e.r.). Heteroaromatic groups such as thiophene (**2pa**), pyrazole (**2qa**), and indole (**2ra**) were compatible, representing pharmaceutically relevant motifs (up to 99% yield, 94:6 e.r.). Additional highlights are the suitability of *N*-allylazetidinium salts (**2ac**, **2ic**), the tolerance of the reaction to 3-aryloxy (**2ia**--**2ja,** up to 99% yield, 93.5:6.5 e.r.), 3-alkoxy (**2ka**--**2mb**), and 3-phthalimido (**2sa**) groups, and the synthesis of enantioenriched γ-fluoroamines **2oa** and **2va**--**2ua** featuring a tetrasubstituted stereogenic carbon. Furthermore, **2ta** bearing an ester group stands out as an immediate precursor to enantioenriched fluorinated β-lactams and β-amino acids.^[@ref16]^ Tertiary fluoride **2wa** was accessed in good yield with moderate enantioselectivity. A single recrystallization of **2sa**, **2ta** and **2wa** afforded these fluorinated amines in high enantioselectivity or as a single enantiomer. Substrates mono- or *bis*-alkylated at position 3 were less successful ([Scheme S7](http://pubs.acs.org/doi/suppl/10.1021/jacs.0c05131/suppl_file/ja0c05131_si_001.pdf)).^[@cit13a]^ Single-crystal X-ray diffraction analysis of **2ma**·HCl and **3ab**·HCl ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}A) enabled the assignment of the absolute configuration (*(S)-*catalyst affords *(S)-*product).^[@ref17]^

![Reaction Scope\
Reactions were performed on a 0.1 mmol scale, except for **1sa**, **1ta**, and **1wa** (0.5--1 mmol scale). Absolute configurations were assigned by analogy to (*S*)-**2ma** for all products except **2oa** and **2ua**--**2wa** featuring a tetrasubstituted stereogenic carbon. The e.r. values in parentheses were obtained after a single recrystallization.\
20 mol% cat.](ja0c05131_0004){#sch2}

![(A) Gram-Scale Reactions and Deprotection. (B) Enantioselective Synthesis of Fluorinated Lorcaserin](ja0c05131_0005){#sch3}

This new catalytic protocol enabled the preparative-scale synthesis of γ-fluoroamines **3aa** and **3ab** ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}A). The reaction of 1 g of **1aa** was conducted with a lower catalyst loading (3 mol%) and no compromise in e.r. relative to the smaller-scale reaction. Deprotection and a single recrystallization gave the primary γ-fluoroamine **3aa** with 99:1 e.r. A similar protocol afforded enantioenriched secondary γ-fluoroamine **3ab** with 98.5:1.5 e.r. The synthesis of the fluorinated analogue of lorcaserin,^[@ref18]^ a selective serotonin 2C receptor agonist that is FDA-approved for chronic weight management, illustrates the value of the method for accessing valuable pharmaceutical motifs ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}B).

Further experimentation was undertaken to gain more insight into this process. (i) The reaction of **1aa** with 1 equiv of \[(*S*)-**D**·F\]^−^\[*n*Bu~4~N\]^+^ formed in situ or preformed from *n*Bu~4~N^+^F^--^·3H~2~O in 1,2-DCE (0.25 M) afforded **2aa** in 30% yield with 96:4 e.r. This result confirms the involvement of \[(*S*)-**D**·F\]^−^ for enantiocontrol ([Scheme S5](http://pubs.acs.org/doi/suppl/10.1021/jacs.0c05131/suppl_file/ja0c05131_si_001.pdf)) and highlights the detrimental impact of water on the yield ([Table S5](http://pubs.acs.org/doi/suppl/10.1021/jacs.0c05131/suppl_file/ja0c05131_si_001.pdf)). (ii) Exchanging OTf^−^ of **1aa** with PF~6~^−^ gave **2aa** with identical e.r. (96:4) but in only 31% yield ([Table S6](http://pubs.acs.org/doi/suppl/10.1021/jacs.0c05131/suppl_file/ja0c05131_si_001.pdf)). This observation indicates that the counteranion influences the efficacy of phase-transfer and advocates against anion-binding catalysis. This is further supported by NMR studies showing the stronger binding preference of the catalyst for fluoride compared with other anions (F^--^ ≫ TfO^--^ ≈ BF~4~^--^ \> PF~6~^--^).^[@cit13a]^ (iii) The linear relationship between the enantiopurities of the catalyst and product supports the involvement of a single urea catalyst in the enantiodetermining step ([Table S7](http://pubs.acs.org/doi/suppl/10.1021/jacs.0c05131/suppl_file/ja0c05131_si_001.pdf)). (iv) When diastereomerically pure *N*-methyl-substituted *cis*-**1a** or *trans*-**1a** was subjected to asymmetric fluorination under the standard reaction conditions, fluoroamine (*S*)-**2a** was formed with comparable e.r. values (80.5:19.5 and 80:20, respectively; [Table S4](http://pubs.acs.org/doi/suppl/10.1021/jacs.0c05131/suppl_file/ja0c05131_si_001.pdf)).

Finally, we turned our attention to the origin of enantioconvergence for this transformation. The TSs for fluorination of **1a** mediated by catalyst (*S*)-**D** were computed using density functional theory (DFT).^[@ref19]^ An ensemble of TSs were optimized for both *cis* and *trans* substrates ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). With the *cis* substrate (major diastereomer), both **TS**~**Major**~**-cis** and **TS**~**Minor**~**-cis** feature a face-to-face π interaction between the phenyl group at the 3-position of the substrate and the catalyst ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}Ai), orienting the substrate in the catalytic pocket. In contrast, the benzhydryl groups point in different directions. In **TS**~**Major**~**-cis**, the azetidinium ion adopts its favored conformation, with an intramolecular CH···π interaction worth approximately 2--5 kJ/mol ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}Aii). In **TS**~**Minor**~**-cis**, this is compensated by an aromatic edge-to-face interaction of the benzhydryl group with the catalyst BINAM backbone ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}Aiii). When computed with an *N*-ethyl substituent (**1ab**), the *(S)*-catalyst affords the *(S)*-product with 91:9 e.r., consistent with the experimental enantioselectivity of 96:4 e.r. Comparison of the lowest-energy TS, **TS**~**Major**~**-cis**, to the TS for the major product with the *trans* substrate, **TS**~**Major**~**-trans**, shows remarkable similarity, with excellent superposition of the catalyst, fluoride, and substrate. The only exception is the reversal of the configuration at nitrogen, which causes the sterically demanding benzhydryl group to point in a different direction ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}B). The enantioconvergence of the diastereomers originates from the projection of the azetidinium *N*-substituents away from the catalyst and the resulting indifference to the configuration at nitrogen.^[@ref20]^

![Computed TSs for fluorination of **1a**. (A) TSs with *cis*-**1a** and key structural features. (B) Origin of the enantioconvergence of *cis*-**1a** and *trans*-**1a** demonstrated through the structural similarity of the most favorable TSs for the two diastereomers of the substrate.](ja0c05131_0002){#fig2}

In conclusion, this study provides new insights into HB-PTC and its application to high-value fluorine-containing molecules. Neutral *N*-alkyl-*bis*(urea) catalysts are more effective at fluoride binding than azetidinium ions, a feature enabling efficient enantioselective ring opening with CsF for the synthesis of γ-fluoroamines. As the use of ammonium salts as substrates is uncommon in asymmetric catalysis,^[@ref21]^ the principles outlined here may encourage further studies to transform ionic starting materials into enantioenriched products by applying HB-PTC.
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